Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis
PHASE4CompletedINTERVENTIONAL
Timeline
Start Date
September 30, 2002
Primary Completion Date
February 28, 2005
Study Completion Date
February 28, 2006
Conditions
House Dust Mite Allergy
Interventions
BIOLOGICAL
House dust mite Novo Helisen Depot
Trial Locations (1)
21465
Allergopharma GmbH & Co. KG, Reinbek
All Listed Sponsors
lead
Allergopharma GmbH & Co. KG
INDUSTRY
NCT00263549 - Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis | Biotech Hunter | Biotech Hunter